Lista de obras - Emmanuel Scotet - Dominio Público Uruguay

+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.

artículo científico publicado en 2002

A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.

artículo científico publicado en 2012

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

artículo científico publicado en 2011

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.

artículo científico publicado en 2015

An X-ray Vision for Phosphoantigen Recognition

artículo científico publicado en 2019

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia

artículo científico publicado en 2016

Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors

scientific article published on 23 September 2020

Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.

scientific article published on May 2008

Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation

artículo científico publicado en 2017

CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis

artículo científico publicado en 2014

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

scientific article published on 28 August 2019

Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.

artículo científico publicado en 2013

Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer

artículo científico publicado en 2015

Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.

artículo científico publicado en 2009

Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.

artículo científico publicado en 2017

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2 ⬇️

artículo científico publicado el 9 de julio de 1998

Full Restoration of Brucella-Infected Dendritic Cell Functionality through Vγ9Vδ2 T Helper Type 1 Crosstalk ⬇️

artículo científico publicado el 22 de agosto de 2012

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

artículo científico publicado en 2006

IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors.

artículo científico publicado en 2018

IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.

artículo científico publicado en 2009

Immunodominant CD8 T cell response to Epstein-Barr virus ⬇️

artículo científico publicado el 1 de septiembre de 2001

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

artículo científico publicado en 2018

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

artículo científico publicado en 2012

Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?

artículo científico publicado en 2009

Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells

scientific article published on 01 October 2001

Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells

artículo científico publicado en 2014

Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells

artículo científico publicado en 2004

NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells

artículo científico publicado en 2019

NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.

artículo científico publicado en 2010

Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek ⬇️

artículo científico publicado el 1 de marzo de 1995

Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo ⬇️

artículo científico publicado el 8 de julio de 2013

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

artículo científico publicado en 2016

Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?

artículo científico publicado en 2007

Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.

scientific article published on 07 March 2017

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

scientific article published on 01 September 2018

Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.

artículo científico publicado en 2016

Synergism and complementarity between human CD1 AND MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds.

artículo científico publicado en 2005

Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.

artículo científico publicado en 2017

The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells

artículo científico publicado en 2014

The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.

artículo científico publicado en 2017

The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies

artículo científico publicado en 2012

The interplay between the duration of TCR and cytokine signaling determines T cell polarization

scientific article published on 01 December 1999

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.

artículo científico publicado en 2018

Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I

scientific article published on 01 January 2005

Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells

artículo científico publicado en 2011

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.

artículo científico publicado en 2014

Lista de obras de Emmanuel Scotet

+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.

A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.

An X-ray Vision for Phosphoantigen Recognition

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia

Beyond CAR T cells: Engineered Vγ9Vδ2 T cells to fight solid tumors

Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.

Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation

CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivo

Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.

Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer

Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.

Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.

Exon III splicing switch of fibroblast growth factor (FGF) receptor-2 and -3 can be induced by FGF-1 or FGF-2 ⬇️

Full Restoration of Brucella-Infected Dendritic Cell Functionality through Vγ9Vδ2 T Helper Type 1 Crosstalk ⬇️

Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors

IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors.

IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.

Immunodominant CD8 T cell response to Epstein-Barr virus ⬇️

Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?

Molecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cells

Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T Cells

Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells

NKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma Cells

NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.

Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek ⬇️

Repeated Systemic Administrations of Both Aminobisphosphonates and Human Vγ9Vδ2 T Cells Efficiently Control Tumor Development In Vivo ⬇️

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?

Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.

Synergism and complementarity between human CD1 AND MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds.

Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.

The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells

The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.

The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific Antibodies

The interplay between the duration of TCR and cytokine signaling determines T cell polarization

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.

Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I

Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells

Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.